G Hoctin-Boes

3.2k total citations · 1 hit paper
12 papers, 2.4k citations indexed

About

G Hoctin-Boes is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, G Hoctin-Boes has authored 12 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in G Hoctin-Boes's work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal and Anal Carcinomas (3 papers). G Hoctin-Boes is often cited by papers focused on Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal and Anal Carcinomas (3 papers). G Hoctin-Boes collaborates with scholars based in Netherlands, France and United Kingdom. G Hoctin-Boes's co-authors include J. Houghton, Anthony Howell, Jack Cuzick, Gershon Y. Locker, J S Tobias, Mitch Dowsett, John Forbes, M Baum, A. Buzdar and W. Distler and has published in prestigious journals such as The Lancet, Gut and The Lancet Oncology.

In The Last Decade

G Hoctin-Boes

12 papers receiving 2.3k citations

Hit Papers

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Com... 2005 2026 2012 2019 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    2005 1.7k citations Anthony Howell, Jack Cuzick et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Hoctin-Boes Netherlands 8 1.5k 1.4k 958 392 278 12 2.4k
J S Tobias United Kingdom 11 1.1k 0.7× 1.3k 1.0× 715 0.7× 402 1.0× 291 1.0× 16 2.3k
Alwynne Tidy United Kingdom 11 1.2k 0.8× 1.5k 1.1× 604 0.6× 284 0.7× 302 1.1× 17 2.2k
JF Forbes Australia 12 1.9k 1.3× 1.7k 1.2× 1.4k 1.4× 471 1.2× 343 1.2× 26 3.0k
A. Buzdar United States 7 1.2k 0.8× 1.2k 0.9× 846 0.9× 356 0.9× 253 0.9× 16 2.0k
Monica Castiglione Switzerland 17 1.3k 0.9× 1.4k 1.1× 1.3k 1.4× 522 1.3× 258 0.9× 26 2.4k
M Baum United Kingdom 11 2.4k 1.6× 2.0k 1.5× 1.6k 1.7× 573 1.5× 455 1.6× 34 3.6k
Gun Anker Norway 22 1.2k 0.8× 1.3k 1.0× 914 1.0× 396 1.0× 536 1.9× 38 2.4k
Manuela Rabaglio Switzerland 22 779 0.5× 1.2k 0.9× 819 0.9× 589 1.5× 298 1.1× 83 2.0k
TJ Powles United Kingdom 19 1.2k 0.8× 991 0.7× 472 0.5× 200 0.5× 346 1.2× 39 1.9k
Reena S. Cecchini United States 20 1.1k 0.7× 1.8k 1.3× 959 1.0× 422 1.1× 393 1.4× 49 2.9k

Countries citing papers authored by G Hoctin-Boes

Since Specialization
Citations

This map shows the geographic impact of G Hoctin-Boes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Hoctin-Boes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Hoctin-Boes more than expected).

Fields of papers citing papers by G Hoctin-Boes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Hoctin-Boes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Hoctin-Boes. The network helps show where G Hoctin-Boes may publish in the future.

Co-authorship network of co-authors of G Hoctin-Boes

This figure shows the co-authorship network connecting the top 25 collaborators of G Hoctin-Boes. A scholar is included among the top collaborators of G Hoctin-Boes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Hoctin-Boes. G Hoctin-Boes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Appels, Natalie M. G. M., Kai Chio Chan, T C Stephens, et al.. (2008). Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer. British Journal of Cancer. 98(12). 1951–1958. 13 indexed citations
2.
Buzdar, Aman U., Anthony Howell, Jack Cuzick, et al.. (2006). Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. The Lancet Oncology. 7(8). 633–643. 355 indexed citations
3.
Howell, Anthony, Jack Cuzick, M Baum, et al.. (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. The Lancet. 365(9453). 60–62. 1715 indexed citations breakdown →
4.
Wagenaar, Hendrik, N. Colombo, Ignace Vergote, et al.. (2001). Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study. Gynecologic Oncology. 81(3). 348–354. 57 indexed citations
5.
Akaza, Hideyuki, N Saijo, Kazuhiro Aiba, et al.. (2001). [Platinum compounds in cancer therapy--past, present, and future].. PubMed. 28(5). 625–35. 4 indexed citations
6.
Dixon, John, Lorna Renshaw, Christopher Bellamy, et al.. (2000). The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer. Clinical Cancer Research. 6(6). 4 indexed citations
7.
Dixon, J. Michael, Lorna Renshaw, Christopher Bellamy, et al.. (2000). The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.. PubMed. 6(6). 2229–35. 124 indexed citations
8.
Klijn, J.G.M., R.W. Blarney, Francesco Boccardo, et al.. (1998). A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT). European Journal of Cancer. 34. S90–S90. 11 indexed citations
9.
10.
11.
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J S Tobias Breakdown of academic impact, for papers by Alwynne Tidy Breakdown of academic impact, for papers by JF Forbes Breakdown of academic impact, for papers by A. Buzdar Breakdown of academic impact, for papers by Monica Castiglione Breakdown of academic impact, for papers by M Baum Breakdown of academic impact, for papers by Gun Anker Breakdown of academic impact, for papers by Manuela Rabaglio Breakdown of academic impact, for papers by TJ Powles Breakdown of academic impact, for papers by Reena S. Cecchini
Rankless by CCL
2026